SolidWorld Group: signed a distribution agreement with TWIN Helix for the Italian market of Electrospider

Treviso, December 13, 2024– SolidWorld Group S.p.A., a company listed on the Euronext Growth Milan market (ticker S3D) and head of the Group leader in the sectors of industrial 3D design and printing technologies, 3D bio-manufacturing and latest generation machinery lines for photovoltaic panel production, is pleased to announce the signing of a distribution agreement with TWIN Helix, a leader in the commercialization of innovative technologies for scientific research laboratories in the biomedical field. The agreement, initially set for one year with automatic renewal, covers the distribution of the Electrospider 3D bioprinter in Italy, a revolutionary technology poised to redefine the boundaries of biomedical, pharmacological, and other applications.

This new collaboration aims to further expand the use of bioprinting technologies in emerging fields such as applied research and industrial production. SolidWorld Group and TWIN Helix share the goal of providing cutting-edge tools to support researchers in competing within a rapidly evolving scientific landscape.

The partnership with TWIN Helix marks a significant step for SolidWorld in consolidating its leadership position in 3D printing applied to the biomedical sector.

“We are delighted to announce this collaboration with TWIN Helix, a strategic partner who shares our vision of innovation and progress in the life sciences sector. This agreement represents a turning point in bringing our Electrospider technology to a broader audience, supporting scientific research with state-of-the-art tools” – said Roberto Rizzo, President and CEO of SolidWorld Group S.p.A.

TWIN Helix, with nearly a decade of experience in 3D bioprinting for basic research, has played a crucial role in making the Italian market one of the most advanced in Europe and globally, not only in terms of the number of installed systems but also in the volume of scientific research published by its clients. Through this collaboration, the company aims to penetrate the applied research and production sectors of bioprinting.

The patented multiscale and multimaterial Electrospider 3D bioprinter is designed to meet cross-sector needs. Already successfully utilized in biomedical and oncology fields, the technology also finds applications in pharmacological and cosmetic research for testing on replicated tissues, as well as in the fashion industry for creating sustainable leather goods. This versatility, combined with precision and efficiency, makes Electrospider an indispensable tool for those seeking innovative and sustainable solutions.

***

SolidWorld Group S.p.A. . is the parent of a group of 10 companies operating in the industrial, biomedical and solar areas founded in the early 2000s by engineer Roberto Rizzo. Listed since July 6, 2022 on the Euronext Growth Milan segment of Borsa Italiana (ticker S3D), the Group is a leading developer and integrator of the latest and most comprehensive digital 3D software and hardware for manufacturing companies, supporting and accelerating their journey to Industry 5.0. Thanks to SolidWorld, all stages of production – as far as sale and recycling – are integrated using technologies that make the production process faster and more sustainable and efficient. It operates through 16 offices and 3 technology hubs and has over 220 employees and more than 10,000 client enterprises. In 2023, the Group began mass production of Electrospider, a 3D bioprinter capable of reproducing human cell tissues and organs. The acquisition of Valore BF 3d S.r.l. was finalized in 2023, which SolidWorld saw acquire a new client base. In 2023 it completed the transfer of a technology business unit from Formula E S.r.l., a company of the Vismunda S.r.l. Group, a world leader in automation for equipment focusing on the renewable energy sector which enabled SolidWorld Group to enter the solar market. In the first half of 2024, the SolidWorld Group reported revenues of Euro 30.9 million, value of production of Euro 40.1 million, and EBITDA of Euro 6.3 million.. www.solidworldgroup.it

CONTACTS
Investor Relations Manager
Elisabetta Cammarata
investor@solidworld.it

IR Corporate Media Advisor TWIN
solidworld@twin.services
Federico Bagatella | T. +39 331 8007258
Morena Azzi | T. +39 331 1070477